Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Deep-learning screening for coronary artery disease on routine chest CT

Official title: Deep Learning-Based Opportunistic Screening of Coronary Artery Disease on Non-Contrast Chest CT: A Multicenter Study

Run by Zhejiang Chinese Medical University · NCT07181512 · Data updated 2026-11-12

This project will test whether deep learning can find coronary artery calcification on routine non-contrast chest CT in adults who also had coronary CT angiography.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorZhejiang Chinese Medical University
Government
Drugs / interventionsradiation
Locations2 sites (Hangzhou, Zhejiang and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedApril 20, 2026
Study endsDecember 31, 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT07181512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults (≥18) who had both non-contrast chest CT and CCTA within 30 days with coronary segments clearly visible on the non-contrast scan.

Probably not a fit

Patients with motion or metal artifacts, coronary stents, completely obscured vessel lumens, or without matched CCTA within 30 days are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, retrospective analysis uses de-identified imaging from adults who underwent both non-contrast chest CT and coronary CT angiography (CCTA) within 30 days. Deep-learning models will be developed and validated to analyze calcified coronary segments visible on non-contrast chest CT, using CCTA as the reference standard. No additional imaging, radiation, or interventions are performed and the institutional review board approved a waiver of written consent. Segments with motion or metal artifacts, stents, or completely obscured lumens will be excluded and models will be tested across participating hospitals to assess generalizability.

Why it matters

Potential benefit: If successful, this could enable low-cost, opportunistic screening for coronary artery disease using existing chest CT scans and help identify high-risk people earlier.

How similar studies have gone: Prior research using calcium scoring and machine learning on non-contrast chest CT has shown promising results, but multicenter validation remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years
2. Patients who underwent both non-contrast chest CT and coronary CT angiography (CCTA) within 30 days
3. Coronary segments clearly visualized on non-contrast chest CT

Exclusion Criteria:

1. Segments with motion artifacts, metal artifacts, or stents preventing analysis
2. Vessel lumen completely obscured by calcification (unrecognizable vascular course)
3. Inability to match coronary segment location between non-contrast chest CT and CCTA

Where it's running

  • The First Affiliated Hospital of Zhejiang Chinese Medical University
    Hangzhou, Zhejiang, China
    Recruiting
  • The First Affiliated Hospital of Ningbo University
    Ningbo, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.